This review outlines the management of myocardial infarction, emphasizing the high early mortality and the roles of key therapies such as aspirin, thrombolytics, angioplasty, ACE inhibitors, and beta-blockers.
Myocardial infarction is dangerous. Among people in the UK who develop an acute coronary event, in particular myocardial infarction, around 35-40% die within 24 hours of the condition's onset and 40-50% within a month. Here, we discuss management up to and following admission to hospital, concentrating on the use of aspirin, thrombolytic therapy, coronary angioplasty, angiotensin-converting-enzyme (ACE) inhibitors and beta-blockers.
No takes yet. Share an insight, caveat, or question.
A 2000 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More on Dual antiplatelet therapyMore from Drug and Therapeutics Bulletin